• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯氮卓固体分散体的研究

An investigation on the solid dispersions of chlordiazepoxide.

作者信息

Nokhodchi Ali, Talari Roya, Valizadeh Hadi, Jalali Mohammad Barzegar

机构信息

Medway School of Pharmacy, the Universities of Kent and Greenwich, Central Ave., Chatham Maritime, ME4 4TB, Kent, UK;

出版信息

Int J Biomed Sci. 2007 Sep;3(3):211-6.

PMID:23675046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3614681/
Abstract

The aim of this study was to prepare solid dispersions of chlordiazepoxide techniques to improve its dissolution rate. To this end, three techniques namely, two solvent methods and co-grinding technique were used. Solid dispersions of chlordiazepoxide in polyvinylpyrrolidone (PVP), Eudragit E100, Mannitol and Sorbitol with two different ratios of drug to carrier (5:5 and 1:9) were prepared. These solid dispersions were evaluated using dissolution tester to monitor dissolution behaviour and Fourier-transform infrared spectroscopy to investigate interaction between the drug and carriers in solid dispersion samples. Solid dispersion of chlordiazepoxide with all three carriers (PVP, mannitol and eudragit E) prepared by solvent method showed considerable increase in the dissolution rate of chlordiazepoxide in comparison with physical mixture and pure drug at different pH values. According to the results of this investigation cogrinding technique yields solid dispersions with a less improved dissolution rate than does the solvent deposition technique. Infrared studies showed no interaction between chlordiazepoxide and carriers in solid dispersions in solid state.

摘要

本研究的目的是采用技术制备氯氮卓的固体分散体,以提高其溶出速率。为此,使用了三种技术,即两种溶剂法和共研磨技术。制备了氯氮卓在聚乙烯吡咯烷酮(PVP)、丙烯酸树脂E100、甘露醇和山梨醇中的固体分散体,药物与载体的比例为两种不同比例(5:5和1:9)。使用溶出度测试仪评估这些固体分散体的溶出行为,并使用傅里叶变换红外光谱研究固体分散体样品中药物与载体之间的相互作用。通过溶剂法制备的氯氮卓与所有三种载体(PVP、甘露醇和丙烯酸树脂E)的固体分散体在不同pH值下,与物理混合物和纯药物相比,氯氮卓的溶出速率有显著提高。根据本研究结果,共研磨技术得到的固体分散体的溶出速率提高程度低于溶剂沉积技术。红外研究表明,氯氮卓与固态固体分散体中的载体之间没有相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a945/3614681/75b02fd5ba7b/IJBS-3-211_F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a945/3614681/e63adda95bf3/IJBS-3-211_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a945/3614681/21606e949f6b/IJBS-3-211_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a945/3614681/369cead87c20/IJBS-3-211_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a945/3614681/2d9fa456c31c/IJBS-3-211_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a945/3614681/17b84b0905ce/IJBS-3-211_F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a945/3614681/75b02fd5ba7b/IJBS-3-211_F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a945/3614681/e63adda95bf3/IJBS-3-211_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a945/3614681/21606e949f6b/IJBS-3-211_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a945/3614681/369cead87c20/IJBS-3-211_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a945/3614681/2d9fa456c31c/IJBS-3-211_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a945/3614681/17b84b0905ce/IJBS-3-211_F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a945/3614681/75b02fd5ba7b/IJBS-3-211_F6.jpg

相似文献

1
An investigation on the solid dispersions of chlordiazepoxide.氯氮卓固体分散体的研究
Int J Biomed Sci. 2007 Sep;3(3):211-6.
2
Physicochemical characterization and in vitro dissolution studies of solid dispersions of ketoprofen with PVP K30 and d-mannitol.酮洛芬与 PVP K30 和 D-甘露醇固体分散体的理化性质表征及体外溶出度研究。
Saudi Pharm J. 2013 Jan;21(1):77-84. doi: 10.1016/j.jsps.2011.12.007. Epub 2011 Dec 24.
3
Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100.吲哚美辛与聚乙二醇6000、聚山梨酯52、乳糖、山梨醇、糊精和丙烯酸树脂E100固体分散体的物理化学表征
Drug Dev Ind Pharm. 2004 Mar;30(3):303-17. doi: 10.1081/ddc-120030426.
4
Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.洛伐他汀与聚乙二醇4000和聚乙烯吡咯烷酮K30固体分散体的物理化学表征及溶出度研究
Pharm Dev Technol. 2007;12(1):21-33. doi: 10.1080/10837450601166510.
5
Development and physicochemical characterization of sirolimus solid dispersions prepared by solvent evaporation method.溶剂蒸发法制备西罗莫司固体分散体的研制及其物理化学表征
Adv Pharm Bull. 2014 Dec;4(4):369-74. doi: 10.5681/apb.2014.054. Epub 2014 Aug 10.
6
Development and characterization of solid dispersion for dissolution improvement of furosemide by cogrinding method.通过共研磨法制备用于改善呋塞米溶出度的固体分散体及其表征
Adv Pharm Bull. 2014 Dec;4(4):391-9. doi: 10.5681/apb.2014.058. Epub 2014 Aug 10.
7
Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers.塞来昔布固体分散体的制备与表征;泊洛沙姆 188 与聚维酮 K30 作为载体的比较。
Iran J Basic Med Sci. 2014 May;17(5):322-31.
8
Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.选择合适的聚合物用于超临界流体辅助制备卡维地洛固体分散体。
Int J Pharm. 2019 Jan 10;554:190-200. doi: 10.1016/j.ijpharm.2018.11.015. Epub 2018 Nov 8.
9
Preparation and characterization of solid dispersions of carvedilol with PVP K30.卡维地洛与聚维酮K30固体分散体的制备与表征
Res Pharm Sci. 2010 Jan;5(1):49-56.
10
Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers.吡罗昔康与亲水性载体的固体分散体的制备与表征
Drug Dev Ind Pharm. 2007 Jan;33(1):45-56. doi: 10.1080/03639040600814965.

引用本文的文献

1
Preparation and Evaluation of Berberine-Excipient Complexes in Enhancing the Dissolution Rate of Berberine Incorporated into Pellet Formulations.制备和评价小檗碱赋形剂复合物以提高小檗碱微丸制剂的溶出速率。
AAPS PharmSciTech. 2024 Jul 3;25(6):154. doi: 10.1208/s12249-024-02863-1.
2
Recent Patents on Solid Dispersions Emphasize Promising Benefits in Solubility Enhancement of Poorly Water-soluble Drugs.固体分散体的最新专利强调了在提高难溶性药物溶解度方面的显著优势。
Recent Pat Nanotechnol. 2025;19(2):216-240. doi: 10.2174/0118722105229356231030065938.
3
Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics.

本文引用的文献

1
Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers.吡罗昔康与亲水性载体的固体分散体的制备与表征
Drug Dev Ind Pharm. 2007 Jan;33(1):45-56. doi: 10.1080/03639040600814965.
2
Floating drug delivery systems: a review.漂浮药物递送系统:综述
AAPS PharmSciTech. 2005 Oct 19;6(3):E372-90. doi: 10.1208/pt060347.
3
Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose.难溶性药物在含乙基纤维素和羟丙基甲基纤维素的缓释固体分散体系统中的溶出机制
难溶性药物和治疗剂的生物利用度提高技术
Biomedicines. 2022 Aug 23;10(9):2055. doi: 10.3390/biomedicines10092055.
4
Star-Shaped Poly(furfuryl glycidyl ether)-Block-Poly(glyceryl glycerol ether) as an Efficient Agent for the Enhancement of Nifuratel Solubility and for the Formation of Injectable and Self-Healable Hydrogel Platforms for the Gynaecological Therapies.星形聚(糠基缩水甘油醚)-嵌段-聚(甘油甘油醚)作为一种有效的增溶剂,可提高硝呋太尔的溶解度,并可形成用于妇科治疗的可注射和自修复水凝胶平台。
Int J Mol Sci. 2021 Aug 4;22(16):8386. doi: 10.3390/ijms22168386.
5
Development and characterization of nifedipine-amino methacrylate copolymer solid dispersion powders with various adsorbents.含不同吸附剂的硝苯地平-甲基丙烯酸氨基酯共聚物固体分散体粉末的研制与表征
Asian J Pharm Sci. 2017 Jul;12(4):335-343. doi: 10.1016/j.ajps.2017.01.002. Epub 2017 Jan 18.
6
Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs.用于提高难溶性药物溶出度和生物利用度的药物分散技术。
Pharmaceutics. 2018 Jun 23;10(3):74. doi: 10.3390/pharmaceutics10030074.
7
Investigation into the Emerging Role of the Basic Amino Acid L-Lysine in Enhancing Solubility and Permeability of BCS Class II and BCS Class IV Drugs.研究基本氨基酸 L-赖氨酸在提高 BCS Ⅱ类和 BCS Ⅳ类药物溶解度和渗透性方面的新作用。
Pharm Res. 2018 Jun 18;35(8):160. doi: 10.1007/s11095-018-2443-0.
8
Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation.基于β-环糊精的水凝胶微粒用于增强瑞舒伐他汀溶解度的研发:体外和体内评价
Drug Des Devel Ther. 2017 Oct 24;11:3083-3096. doi: 10.2147/DDDT.S143712. eCollection 2017.
9
The Effect of Tween 20, 60, and 80 on Dissolution Behavior of Sprionolactone in Solid Dispersions Prepared by PEG 6000.吐温20、60和80对聚乙二醇6000制备的固体分散体中螺内酯溶出行为的影响
Adv Pharm Bull. 2015 Sep;5(3):435-41. doi: 10.15171/apb.2015.059. Epub 2015 Sep 19.
10
Studies on dissolution enhancement of prednisolone, a poorly water-soluble drug by solid dispersion technique.采用固体分散技术提高难溶性药物泼尼松龙溶出度的研究。
Adv Pharm Bull. 2011;1(1):48-53. doi: 10.5681/apb.2011.007. Epub 2011 Jul 20.
Int J Pharm. 2005 Sep 30;302(1-2):95-102. doi: 10.1016/j.ijpharm.2005.06.019.
4
A three step supercritical process to improve the dissolution rate of eflucimibe.一种提高依氟米贝溶解速率的三步超临界过程。
Eur J Pharm Sci. 2005 Oct;26(2):184-93. doi: 10.1016/j.ejps.2005.05.011.
5
Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.通过固体分散体和包合物提高蛇葡萄素的溶解度。
J Pharm Biomed Anal. 2005 Jul 1;38(3):457-64. doi: 10.1016/j.jpba.2005.01.030. Epub 2005 Mar 2.
6
Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100.吲哚美辛与聚乙二醇6000、聚山梨酯52、乳糖、山梨醇、糊精和丙烯酸树脂E100固体分散体的物理化学表征
Drug Dev Ind Pharm. 2004 Mar;30(3):303-17. doi: 10.1081/ddc-120030426.
7
Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.通过传统溶剂蒸发法和超临界法制备的卡马西平在聚乙烯吡咯烷酮K30中的固体分散体。
Int J Pharm. 2004 Mar 19;272(1-2):1-10. doi: 10.1016/j.ijpharm.2003.11.025.
8
Theophylline particle design using chitosan by the spray drying.采用壳聚糖通过喷雾干燥法进行茶碱颗粒设计。
Int J Pharm. 2004 Feb 11;270(1-2):167-74. doi: 10.1016/j.ijpharm.2003.11.001.
9
Enhanced bioavailability of piroxicam using Gelucire 44/14 and labrasol: in vitro and in vivo evaluation.使用Gelucire 44/14和Labrasol提高吡罗昔康的生物利用度:体内外评价
Eur J Pharm Biopharm. 2003 Nov;56(3):453-9. doi: 10.1016/s0939-6411(03)00142-5.
10
Design of sustained-release nitrendipine microspheres having solid dispersion structure by quasi-emulsion solvent diffusion method.采用准乳液溶剂扩散法制备具有固体分散体结构的硝苯地平缓释微球
J Control Release. 2003 Sep 4;91(3):375-84. doi: 10.1016/s0168-3659(03)00275-x.